The Valley Desk

NCT00216099 · Interventional trial

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer

Overall registry status Completed

Phase 2

Conditions Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov